# TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies

> **NCT07692217** · — · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Hemophilia A
- Factor VIII (FVIII)

## Interventions

- **DRUG:** Half-life factor VIII based replacement therapy
- **DRUG:** Non-FVIII based replacement therapy

## Key facts

- **NCT ID:** NCT07692217
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-22
- **Primary completion:** 2033-05
- **Final completion:** 2033-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692217, "TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07692217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*